Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
ApÓstolos-Pereira SL, Silva GD, Disserol CCD, Feo LB, Matos AMB, Schoeps VA, Gomes ABAGR, Boaventura M, Mendes MF, Callegaro D. ApÓstolos-Pereira SL, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2020 Jul;78(7):430-439. doi: 10.1590/0004-282X20200056. Epub 2020 Jul 1. Arq Neuropsiquiatr. 2020. PMID: 32609290 Free article.
[Historical aspects of multiple sclerosis].
Moreira MA, Tilbery CP, Lana-Peixoto MA, Mendes MF, Kaimen-Maciel DR, Callegaro D. Moreira MA, et al. Among authors: mendes mf. Rev Neurol. 2002 Feb 16-28;34(4):379-83. Rev Neurol. 2002. PMID: 12022056 Free article. Spanish.
Meningioma growth during interferon beta-1A treatment for multiple sclerosis.
Gama HP, Rocha AJ, Silva CJ, Mendes MF, Veiga JC, Lancellotti CL, Andrade VP, Tilbery CP. Gama HP, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2008 Jun;66(2B):402-4. doi: 10.1590/s0004-282x2008000300024. Arq Neuropsiquiatr. 2008. PMID: 18641881 Free article. No abstract available.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Fragoso YD, Alves-Leon SV, Arruda WO, Carvalho Mde J, Comini-Frota ER, Corrêa ÉC, Ferreira ML, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Mendes MF, Morales RR, Muniz A, Salgado PR, Ruocco HH, Albuquerque LB, Brooks JB, Fêzer L, Georgetto S, Lopes J, Malfetano FR, Meira ID, Oliveira CL, Oliveira FT, Safanelli F, Satomi M. Fragoso YD, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2013 Mar;71(3):137-41. doi: 10.1590/s0004-282x2013000300002. Arq Neuropsiquiatr. 2013. PMID: 23563711 Free article.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Fragoso YD, Mendes MF, Arruda WO, Becker J, Brooks JB, Carvalho Mde J, Comini-Frota ER, Domingues RB, Ferreira ML, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Morales Rde R, Muniz A, Ruocco HH, Salgado PR, Albuquerque LB, Gama RA, Georgeto S, Lopes J, Oliveira CL, Oliveira FT, Safanelli J, Saldanha PC, Satomi M. Fragoso YD, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2013 Oct;71(10):780-2. doi: 10.1590/0004-282X20130121. Arq Neuropsiquiatr. 2013. PMID: 24212514 Free article.
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Fragoso YD, Ferreira ML, Morales Nde M, Arruda WO, Brooks JB, Carneiro DS, Carvalho Mde J, Comini-Frota ER, Correa EC, Damasceno CA, Domingues RB, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Grzesiuk AK, Khouri JM, Kaimen-Maciel DR, Mendes MF, Morales Rde R, Ribeiro SB, Ribeiro TA, Albuquerque LB, Anacleto A, Finkelsztejn J, Gama RA, Lopes J, Oliveira CL, Oliveira FT, Pires LA, Saldanha PC, Souza AH, Silva AE. Fragoso YD, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2013 Oct;71(10):783-7. doi: 10.1590/0004-282X20130122. Arq Neuropsiquiatr. 2013. PMID: 24212515 Free article.
[Cannabinoids in neurology--Brazilian Academy of Neurology].
Brucki SM, Frota NA, Schestatsky P, Souza AH, Carvalho VN, Manreza ML, Mendes MF, Comini-Frota E, Vasconcelos C, Tumas V, Ferraz HB, Barbosa E, Jurno ME. Brucki SM, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2015 Apr;73(4):371-4. doi: 10.1590/0004-282X20150041. Epub 2015 Apr 1. Arq Neuropsiquiatr. 2015. PMID: 25992535 Free article. Portuguese.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Araujo YR, Becker J, Brooks JBB, Correa EC, Damasceno A, Damasceno CAA, Ferreira MLB, Gama PDD, Gama RADD, Gomes S, Goncalves MVM, Grzesiuk AK, Machado SCN, Matta APDC, Mendes MF, Ribeiro TAGJ, Rocha CFD, Ruocco HH, Sato H, Simm RF, Tauil CB, Vasconcelos CCF, Vieira VLF. Fragoso YD, et al. Among authors: mendes mf. Expert Rev Clin Pharmacol. 2016 Apr;9(4):541-546. doi: 10.1586/17512433.2016.1145053. Epub 2016 Feb 21. Expert Rev Clin Pharmacol. 2016. PMID: 26794493
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Arruda WO, Brooks JB, Cal HS, Damasceno CA, Gama PD, Goncalves MV, Jesus CA, Machado SC, Mansur LF, Matta AP, Mendes MF, Morales RR, Nobrega AW Jr, Parolin MK, Peres MP, Ribeiro MC, Ruocco HH, Scherpenhuijzen S, Siquinelli F, Stoney PN, Varela DL, Eboni AC, Spessotto CV, Rocha ET, Lacerda PE. Fragoso YD, et al. Among authors: mendes mf. Arq Neuropsiquiatr. 2017 Jan;75(1):3-8. doi: 10.1590/0004-282X20160173. Arq Neuropsiquiatr. 2017. PMID: 28099554 Free article.
118 results